Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000040

CEO sold 1,900 shares at an average $17.84 ($33,897)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal CEO 2024-07-12 Sale 10b5-1 −300 $18.00 $5,400 336,075 D
Doshi Dipal CEO 2024-07-15 Sale 10b5-1 −1,600 $17.81 $28,497 334,475 D
Open-market sales · 1,900 sh · avg $17.84 · $33,897
Loading xslF345X05/wk-form4_1721162529.xml…